Cargando…

Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds

Hard-to-heal wounds do not heal spontaneously and need long-term care provided by specialists. That burdens the patients as well as the healthcare systems. Such wounds arise from several pathologies, which result in venous leg ulcers (VLU), diabetic foot ulcers (DFU), pressure ulcers (PU), or ulcers...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecová, Jana, Rohlíková, Vladimíra, Šmoldasová, Markéta, Marek, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536360/
https://www.ncbi.nlm.nih.gov/pubmed/37765236
http://dx.doi.org/10.3390/pharmaceutics15092268
_version_ 1785112847332671488
author Pecová, Jana
Rohlíková, Vladimíra
Šmoldasová, Markéta
Marek, Jan
author_facet Pecová, Jana
Rohlíková, Vladimíra
Šmoldasová, Markéta
Marek, Jan
author_sort Pecová, Jana
collection PubMed
description Hard-to-heal wounds do not heal spontaneously and need long-term care provided by specialists. That burdens the patients as well as the healthcare systems. Such wounds arise from several pathologies, which result in venous leg ulcers (VLU), diabetic foot ulcers (DFU), pressure ulcers (PU), or ulcers originating from post-surgical wounds (pSW). Given the complex nature of hard-to-heal wounds, novel treatments are sought to enable wound healing. We tested the clinical efficacy and applicability of fluid comprising hyaluronic acid and iodine complex (HA-I) in the treatment of hard-to-heal wounds. Patients (n = 56) with VLU, DFU, PU, or pSW hospitalised in multiple wound-care centres in the Czech Republic were treated with HA-I. Wound size, classically visible signs of infection, exudation, pain, and wound bed appearance were monitored for 12 weeks. The highest healing rate was in DFU (71.4%), followed by pSW (62.5%), VLU (55.6%), and PU (44.4%). Classical visible signs of infection were resolved within 8 weeks in all types of wounds. Wound bed appearance improved most noticeably in pSW and then in VLU. Exudation was lowered most significantly in DFU and pSW. The highest decrease in pain was in pSW and DFU. The treatment with HA-I successfully led to either complete closure or significant improvement in the wound’s healing. Therefore, the complex of hyaluronic acid and iodine is suitable for the treatment of hard-to-heal wounds of various aetiologies.
format Online
Article
Text
id pubmed-10536360
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105363602023-09-29 Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds Pecová, Jana Rohlíková, Vladimíra Šmoldasová, Markéta Marek, Jan Pharmaceutics Article Hard-to-heal wounds do not heal spontaneously and need long-term care provided by specialists. That burdens the patients as well as the healthcare systems. Such wounds arise from several pathologies, which result in venous leg ulcers (VLU), diabetic foot ulcers (DFU), pressure ulcers (PU), or ulcers originating from post-surgical wounds (pSW). Given the complex nature of hard-to-heal wounds, novel treatments are sought to enable wound healing. We tested the clinical efficacy and applicability of fluid comprising hyaluronic acid and iodine complex (HA-I) in the treatment of hard-to-heal wounds. Patients (n = 56) with VLU, DFU, PU, or pSW hospitalised in multiple wound-care centres in the Czech Republic were treated with HA-I. Wound size, classically visible signs of infection, exudation, pain, and wound bed appearance were monitored for 12 weeks. The highest healing rate was in DFU (71.4%), followed by pSW (62.5%), VLU (55.6%), and PU (44.4%). Classical visible signs of infection were resolved within 8 weeks in all types of wounds. Wound bed appearance improved most noticeably in pSW and then in VLU. Exudation was lowered most significantly in DFU and pSW. The highest decrease in pain was in pSW and DFU. The treatment with HA-I successfully led to either complete closure or significant improvement in the wound’s healing. Therefore, the complex of hyaluronic acid and iodine is suitable for the treatment of hard-to-heal wounds of various aetiologies. MDPI 2023-09-01 /pmc/articles/PMC10536360/ /pubmed/37765236 http://dx.doi.org/10.3390/pharmaceutics15092268 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pecová, Jana
Rohlíková, Vladimíra
Šmoldasová, Markéta
Marek, Jan
Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title_full Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title_fullStr Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title_full_unstemmed Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title_short Clinical Efficacy of Hyaluronic Acid with Iodine in Hard-to-Heal Wounds
title_sort clinical efficacy of hyaluronic acid with iodine in hard-to-heal wounds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536360/
https://www.ncbi.nlm.nih.gov/pubmed/37765236
http://dx.doi.org/10.3390/pharmaceutics15092268
work_keys_str_mv AT pecovajana clinicalefficacyofhyaluronicacidwithiodineinhardtohealwounds
AT rohlikovavladimira clinicalefficacyofhyaluronicacidwithiodineinhardtohealwounds
AT smoldasovamarketa clinicalefficacyofhyaluronicacidwithiodineinhardtohealwounds
AT marekjan clinicalefficacyofhyaluronicacidwithiodineinhardtohealwounds